Some researchers are investigating the emerging field of chrononutrition, which is based on the timing of when a person eats. According to chrononutrition, coordinating food intake with the body’s daily rhythms will help with management of type 2 diabetes. Read more
Blood glucose control among youth with diabetes has not improved since 2002 levels, and has actually gotten worse in some subgroups, according to data presented at the virtual American Diabetes Association (ADA) 2020 Scientific Sessions. This is despite increased availability of diabetes technology and new therapies in recent decades, and despite more aggressive recommended blood […]
In treating type 2 diabetes, the first-line option is typically metformin. When metformin alone isn’t achieving the patient’s goals, the second and third-line options for pharmacological treatment are complex, with multiple drug classes and multiple drugs within those classes. A new analysis looks at the pros and cons of some key combinations. Read more
Researchers continue examining the relationship between diabetes and coronavirus. In a new study looking specifically at type 1 diabetes, they found that about half the people in the study with type 1 and COVID-19 had abnormally high blood sugar, which demonstrates how COVID-19 can complicate blood sugar control. Read more
A large study of Israeli teen body mass index (BMI) found body mass in adolescence affects risk of developing type 2 as an adult, with young women with obesity most at risk for the disease. Read more
Signs a child may grow up to be susceptible to type 2 diabetes as an adult can be seen in children as young as 8 years of age, researchers say. They looked at the effects of a genetic risk score for developing type 2 diabetes in a large study of children in the UK, and […]
Imeglimin is a new, first-in-class blood-glucose-lowering drug. It is currently in phase 3 trials and has so far proven to be safe and efficient whether used alone or in combination with other drugs to lower A1C in patients with type 2 diabetes. Read more
It’s been well documented since the coronavirus pandemic began that people who have diabetes are at greater risk of severe complications and death from COVID-19. However, some researchers now say the relationship goes both ways: people who have been infected with COVID-19 are at risk of developing stress-related diabetes. Read more
Long term, consistent therapy is essential with metformin for it to be effective in lowering A1c and hospitalization rates. A large UK based study set out to investigate patterns that may lead some patients to discontinuation of metformin therapy. Read more
Diabetic retinopathy, a common complication of diabetes, is a major cause of blindness in adults. A new study found that visual function in diabetic mice was significantly improved after treatment with a single dose of visual chromophore 9-cis-retinal, a vitamin A analog that can form a visual pigment in the retina cells, thereby producing a […]
A new study of body mass index (BMI) and end-stage renal disease (ESRD) suggests obesity may provide a health benefit when it comes to ESRD. The results, from a large Korean study, are surprising and differ from those of earlier studies. Read more
An international team of researchers reported they have developed the world’s smallest, fully functional version of the insulin hormone. This version combines the potency of human insulin with the fast-acting potential of a venom insulin produced by predatory cone snails. Read more
Research on breastfeeding and type 2 diabetes suggests breastfeeding for longer may reduce the risk of future type 2 in women with a history of gestational diabetes. Having gestational diabetes puts women at a 7-fold higher risk of later developing type 2, compared to women who did not have gestational diabetes during their pregnancies. Read more
Researchers at Oregon Health & Science University have developed a new method to help people with type 1 diabetes manage their glucose levels. The system uses artificial intelligence and automated monitoring, and generates recommendations that were similar to those from endocrinologists, the researchers say. Read more
Researchers are looking at whether DPP4 inhibitors, a class of diabetes drugs, may be useful in treating COVID-19. There is some research indicating that DPP4 is directly involved in the cell adhesion and virulence of the virus causing COVID-19, which means inhibition of DPP4 may help treat this novel coronavirus. Read more
Black Americans must be recruited more actively for clinical trial participation, a researcher urges. Data from diabetes clinical trials show that findings often do not apply to blacks and other ethnic minorities in the same way they do to white diabetes patients. Read more
Arterial stiffness is a complication of cardiovascular diseases (CVD), which often affect people with type 2 diabetes. Past research has found lifestyle and behaviors including diet and exercise can have an effect on the development of arterial stiffness. A recent study looked at whether skipping breakfast, specifically, could be a factor. Read more
A Japanese study found that for many patients with type 2 diabetes, self-stigma had a negative effect on how they managed their condition, in addition to negative impacts on self-esteem and self-efficacy. Read more
As researchers seek more knowledge of COVID-19 and why it is so deadly for some patients, studies have found that hypertension, obesity, and diabetes are among the most prevalent comorbidities (that is, conditions that co-exist with the primary disease) in patients with COVID-19. Read more
A new study of diabetes treatment in the United Kingdom has found treatment inertia is greater for black and South Asian type 2 diabetes patients than it is for white people with type 2. The term “treatment inertia” means health professionals are slow to increase the intensity of treatment (such as a raising the medication […]